Extracellular Matrix Dynamics During Remodeling

重塑过程中的细胞外基质动力学

基本信息

  • 批准号:
    10585919
  • 负责人:
  • 金额:
    $ 54.57万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-04-01 至 2026-03-31
  • 项目状态:
    未结题

项目摘要

Project Summary Investigations of ventricular remodeling have focused almost exclusively on changes in collagen deposition and matrix metalloproteinase activity. While such investigations have provided numerous insights into fibrillar changes in the extracellular matrix (ECM), little attention has been paid to the non-fibrillar components of the ECM. Indeed, the ECM is composed of numerous soluble and bound factors. The roles of these various ECM components are diverse, but largely unknown. Moreover, how these factors interact with existing parenchymal cells, the changing and expanding populations of mesenchymal cells, and the transitory leukocytes, such as macrophages, remains to be examined carefully. Despite the complexity of the ECM, our understanding of it remains primitive. In fact, one of the most abundant components of the ECM, hyaluronan (HA), functions through largely cryptic or presumed mechanisms. Ultimately derived from glucose, HA is synthesized by a family of enzymes, known as hyaluronan synthases (HAS). The role of HA may differ dynamically throughout remodeling. Our preliminary data indicate that HA accumulates in the heart early after a myocardial infarction (MI) and its accumulation persists for weeks after MI. We also show that acutely activated fibroblasts contribute to HA production. Given that HA accumulates quickly following MI and activated fibroblasts can increase HA production, this suggests a potential role for a fibroblast-HA axis in acute scar formation. Yet, the persistent accumulation of HA may provoke macrophage-dependent inflammation and contribute to adverse remodeling after the scar has matured. Our preliminary data show that HA directly impairs macrophage function, which may underlie non-resolving inflammation in the remodeling heart. We posit that the changing roles of HA in the acute post-MI setting versus chronic heart failure comprise major, unappreciated events in ventricular remodeling. This insinuates that HA is neither purely pathologic nor purely adaptive. Rather, the role of HA is context dependent. For these reasons, we must understand the regulation of HA production in the failing heart. We posit that acutely after MI, fibroblasts leverage metabolic changes to produce more HA and contribute to scar formation; however, the inexorable accumulation of HA may transition into a contributor to pathology in the chronic phases. Over the course of this project, we will use a battery of gain- and loss-of-function approaches to test the central hypothesis that changes in fibroblast glucose metabolism drive hyaluronan production, which acutely aids in scar formation but chronically prolongs inflammation and promotes adverse remodeling. Regardless of specific outcomes, completion of this project will create fundamental, mechanistic insights into the causes and consequences of changes in the extracellular matrix during ventricular remodeling.
项目摘要 对心室重构的研究几乎完全集中在胶原沉积的变化上。 和基质金属蛋白酶活性。虽然这样的研究为纤维状纤维提供了大量的见解 在细胞外基质(ECM)的变化方面,很少有人关注血管内皮细胞的非纤维成分 ECM。事实上,ECM是由许多可溶的和受约束的因素组成的。这些不同ECM的作用 成分多种多样,但基本上是未知的。此外,这些因素如何与现有的实质相互作用 细胞,间充质细胞的变化和扩大的群体,以及暂时性的白细胞,如 巨噬细胞,仍需仔细检查。尽管ECM很复杂,但我们对它的理解 仍然是原始的。事实上,细胞外基质中含量最丰富的成分之一--透明质酸(HA)具有 在很大程度上是通过神秘或推定的机制。透明质酸最终来源于葡萄糖,由一种 一类酶,称为透明质酸合成酶(HAS)。HA的作用在整个过程中可能动态地不同 改建。我们的初步数据表明,HA在心肌梗死后早期在心脏内积聚 (MI),并在MI后持续数周的积累。我们还表明,急性激活的成纤维细胞有助于 到HA生产。鉴于心肌梗死后透明质酸积聚迅速,活化的成纤维细胞可增加透明质酸 产生,这表明成纤维细胞-HA轴在急性瘢痕形成中的潜在作用。然而,执着的 HA的积聚可能引发巨噬细胞依赖的炎症,并促进不利的重塑 在伤疤成熟后。我们的初步数据显示,HA直接损害巨噬细胞的功能,从而 可能是心脏重塑中未消退炎症的基础。我们假设,房委会在 急性心肌梗死后环境与慢性心力衰竭构成主要的、未被评估的脑室事件 改建。这暗示HA既不是纯粹的病理性,也不是纯粹的适应性。相反,房委会的角色是 取决于上下文。因此,我们必须了解心脏衰竭时产生HA的规律。 我们假设在急性心肌梗死后,成纤维细胞利用代谢变化产生更多的HA,并有助于 瘢痕的形成;然而,HA的不可阻挡的积累可能转变为在 慢性期。在这个项目的过程中,我们将使用一组功能的增益和损耗 检验成纤维细胞葡萄糖代谢变化驱动透明质酸的中心假说的方法 生产,它强烈地帮助形成疤痕,但慢性延长炎症和促进不良反应 改建。无论具体结果如何,这个项目的完成都将创造出根本的、机械性的 对心室重塑过程中细胞外基质变化的原因和后果的洞察。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven P Jones其他文献

Relation of hepatic steatosis to atherogenic dyslipidemia.
肝脂肪变性与动脉粥样硬化性血脂异常的关系。
  • DOI:
    10.1016/j.amjcard.2013.08.001
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Makadia;M. Blaha;Tanya E Keenan;C. Ndumele;Steven P Jones;A. DeFilippis;S. Martin;P. Kohli;R. Conceição;J. Carvalho;K. Nasir;R. Blumenthal;R. Santos
  • 通讯作者:
    R. Santos
Myocardial Reperfusion Injury: Insights Gained from Gene-Targeted Mice.
心肌再灌注损伤:从基因靶向小鼠中获得的见解。
Leukocyte-Endothelial Interactions Following Myocardial Ischemia
心肌缺血后白细胞与内皮细胞的相互作用
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    D. Lefer;Steven P Jones
  • 通讯作者:
    Steven P Jones
PSS144 - Impact of Type 2 Diabetes on Cardiac Stem Cell Phenotype and Therapeutic Efficacy
  • DOI:
    10.1016/j.freeradbiomed.2013.10.563
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Bradford G Hill;Timothy D Cummins;Yiru Guo;Junjie Du;James McCracken;Joshua K Salabei;Petra Haberzettl;Candice R Holden;Steven P Jones;Qianhong Li;Roberto Bolli;Aruni Bhatnagar
  • 通讯作者:
    Aruni Bhatnagar
PSS172 - Regulation of the Hyperproliferative Vascular SmoothMuscle Phenotype by Mitochondrial Fission
  • DOI:
    10.1016/j.freeradbiomed.2013.10.591
  • 发表时间:
    2013-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Joshua K Salabei;Andrew a Gibb;Steven P Jones;Aruni Bhatnagar;Bradford G Hill
  • 通讯作者:
    Bradford G Hill

Steven P Jones的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven P Jones', 18)}}的其他基金

Center for Excellence in Diabetes and Obesity Research
糖尿病和肥胖研究卓越中心
  • 批准号:
    10452732
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
Supplement to Center for Excellence in Diabetes and Obesity Research: Implementing Biomechanics Instrumentation in the Diabetes and Obesity Center
糖尿病和肥胖研究卓越中心的补充:在糖尿病和肥胖中心实施生物力学仪器
  • 批准号:
    10582129
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
Imaging and Physiology Core
影像和生理学核心
  • 批准号:
    10208903
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
Center for Excellence in Diabetes and Obesity Research
糖尿病和肥胖研究卓越中心
  • 批准号:
    10208898
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
TBD
待定
  • 批准号:
    10399838
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
Imaging and Physiology Core
影像和生理学核心
  • 批准号:
    10452737
  • 财政年份:
    2018
  • 资助金额:
    $ 54.57万
  • 项目类别:
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: CORE C
糖尿病和肥胖研究卓越中心:CORE C
  • 批准号:
    8360411
  • 财政年份:
    2011
  • 资助金额:
    $ 54.57万
  • 项目类别:
CENTER OF EXCELLENCE IN DIABETES AND OBESITY RESEARCH: CORE C
糖尿病和肥胖研究卓越中心:CORE C
  • 批准号:
    8168206
  • 财政年份:
    2010
  • 资助金额:
    $ 54.57万
  • 项目类别:
O-GlcNAc Signaling in Heart Failure
心力衰竭中的 O-GlcNAc 信号传导
  • 批准号:
    8292161
  • 财政年份:
    2009
  • 资助金额:
    $ 54.57万
  • 项目类别:
O-GlcNAc Signaling in Heart Failure
心力衰竭中的 O-GlcNAc 信号传导
  • 批准号:
    8103267
  • 财政年份:
    2009
  • 资助金额:
    $ 54.57万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 54.57万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了